291650 — Aptamer Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Aptamer Sciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3,831	-7,116	-13,602	-8,702	-8,622
Depreciation
Amortisation
Non-Cash Items	234	-964	1,874	2,256	1,442
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-316	1,804	-61.9	-331	-3,602
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3,474	-5,776	-11,236	-5,897	-9,670
Capital Expenditures	-7,092	-309	-300	-1,142	-20.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	7,034	-10,345	11,614	15,307	744
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-58	-10,654	11,315	14,165	724
Financing Cash Flow Items	10.1	15.9	23.2	-1,399	-30.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-121	16,643	-62.6	1,968	18,849
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,654	213	15	10,236	9,902